Table 1.

Summary of potential adverse effects analyzed and reported in ATI studies.

Clinical Risks
Acute Retroviral Syndrome	Ruiz [17] Fagard [16] Tarwater [18] Ortiz [19]
Thrombocytopenia	Tarwater [18] Ananworanich [20] Piketty [21]
Cardiovascular, renal, or hepatic disease	SMART study group [6]
Neurological events	Price [23]
Opportunistic disease	SMART study group [6]
Death	SMART study group [6]
Increase in inflammation markers	Kuller [22]
Antiretroviral Drug Resistance
Antiretroviral drug resistance	Arnedo [30] Lau [10]
Effects in Virologic and Immunologic Parameters
Integrated HIV DNA (viral reservoir)	Clarridge [25] Salantes [26] Strongin [27] Papasavvas [28] Montserrat [29]
HIV Transmission
HIV transmission reported cases	Lelièvre [31] Ugarte [32]

Note: ATI: Analytical antiretroviral treatment interruption.